NCT01211028View on ClinicalTrials.gov

Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Peripheral Vascular DiseasesCardiovascular Diseases
Interventions
BIOLOGICAL

Expanded autologous ASCs

Drug: Expanded autologous adipose-derived adult stroma/stem cells

Trial Locations (1)

31059

University Hospital of Toulouse, Rangueil, Toulouse

Sponsors
All Listed Sponsors
collaborator

French Blood Establishment

OTHER

collaborator

Clinical Research Center, Toulouse

OTHER

collaborator

Centre National de la Recherche Scientifique, France

OTHER

lead

University Hospital, Toulouse

OTHER